Dallas, TX -- (SBWIRE) -- 07/07/2011 -- This analysis examines the historical and forecast performance for AstraZeneca in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.

Buy Now: http://www.reportsnreports.com/reports/83955-astrazeneca-pharmavitae-profile.html

Browse All: http://www.reportsnreports.com/market-research/healthcare/

Features and benefits

• Gain insight into AstraZeneca's strategic outlook across the next 6 years

• Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source

Highlights

Strategic insight into the prospects for AstraZeneca over the next six years. Picking out key strengths, weaknesses, opportunities and threats and evaluating the company's prescription pharmaceuticals outlook using a variety of cuts of the historical and forecast sales.

Your key questions answered

• Benchmark AstraZeneca's performance against key rivals in the prescription pharmaceutical sector

• Assess the importance of Crestor, set to become the industry's biggest-selling product, to AstraZeneca's forecast growth performance

• Analyse AstraZeneca's high level of anticipated exposure to flagship product patent expiries through to 2015 and the impact on company strategy

About Us
ReportsnReports is an online library of over 75,000 market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.